K. R. Gammelgaard

Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors

B. Sorensen, M. Jakobsen, Jesper G. Pedersen, 2020, Cancers.

TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection

L. Kristensen, R. Bak, S. Paludan, 2022, The EMBO journal.

Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells.

T. F. Daugaard, A. Nielsen, K. R. Gammelgaard, 2019, Lung cancer.

Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC

T. F. Daugaard, A. Nielsen, F. Dagnæs-Hansen, 2018, Translational oncology.

Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells

A. Nielsen, K. R. Gammelgaard, B. Sørensen, 2020, Translational lung cancer research.

T-cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy

C. Krapp, B. Deleuran, K. Jønsson, 2023, bioRxiv.

Distinct SARS-CoV-2 sensing pathways in pDCs driving TLR7-antiviral vs. TLR2-immunopathological responses in COVID-19

L. Kristensen, R. Bak, S. Paludan, 2021, bioRxiv.

T‐cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy

B. Deleuran, M. Jakobsen, K. R. Gammelgaard, 2023, Journal of extracellular vesicles.